OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature
Roberto Lande, Anna Mennella, Raffaella Palazzo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5102-5102
Open Access | Times Cited: 39

Showing 26-50 of 39 citing articles:

Contributions of Immune Cells and Stromal Cells to the Pathogenesis of Systemic Sclerosis: Recent Insights
Bingying Dai, Liqing Ding, Lijuan Zhao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7

The Role of T Cells in Systemic Sclerosis: An Update
Lazaros I. Sakkas, Dimitrios P. Bogdanos
Immuno (2022) Vol. 2, Iss. 3, pp. 534-547
Open Access | Times Cited: 7

New, Old, and Shared Antibody Specificities in Autoimmune Diseases
Loredana Frasca, Anna Mennella, Raffaella Palazzo
Antibodies (2024) Vol. 13, Iss. 1, pp. 23-23
Open Access | Times Cited: 1

Plasma CXCL4–DNA/RNA Complexes and Anti-CXCL4 Antibodies Modulation in an SSc Cohort under Iloprost Treatment
Anna Mennella, Katia Stefanantoni, Raffaella Palazzo, et al.
Reports — Medical Cases Images and Videos (2024) Vol. 7, Iss. 3, pp. 66-66
Open Access | Times Cited: 1

Innovative cell therapies for systemic sclerosis: available evidence and new perspectives
Alain Lescoat, Monalisa Ghosh, Stephan Kadauke, et al.
Expert Review of Clinical Immunology (2024), pp. 1-15
Closed Access | Times Cited: 1

Type I interferon detection in autoimmune diseases: challenges and clinical applications
Vassilis E. Papadopoulos, Charalampos Skarlis, Maria‐Eleftheria Evangelopoulos, et al.
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 8, pp. 883-903
Closed Access | Times Cited: 9

Insights into origins and specificities of autoantibodies in systemic sclerosis
Eleni Tiniakou, Jonathan Crawford, Erika Darrah
Current Opinion in Rheumatology (2021) Vol. 33, Iss. 6, pp. 486-494
Closed Access | Times Cited: 9

Insights into molecular and clinical characteristics of very early systemic sclerosis
Silvia Bellando-Randone, Francesco Del Galdo, Marco Matucci‐Cerinic
Current Opinion in Rheumatology (2022) Vol. 34, Iss. 6, pp. 351-356
Closed Access | Times Cited: 6

Role of platelet factor 4 in arteriovenous fistula maturation failure: What do we know so far?
Yuxuan Xiao, Roberto I. Vázquez-Padrón, Laisel Martinez, et al.
The Journal of Vascular Access (2022) Vol. 25, Iss. 2, pp. 390-406
Open Access | Times Cited: 5

Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
Raffaella Palazzo, Katia Stefanantoni, Marius Cadar, et al.
Antibodies (2022) Vol. 11, Iss. 4, pp. 77-77
Open Access | Times Cited: 2

Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis
José Eloy Oller-Rodríguez, Elvira Vicens Bernabeu, Roxana González-Mazarío, et al.
Medicina Clínica (English Edition) (2022) Vol. 159, Iss. 8, pp. 359-365
Closed Access

Plasmacytoid Dendritic Cells in Autoimmunity
Dipyaman Ganguly
(2022), pp. 85-106
Closed Access

Previous Page - Page 2

Scroll to top